Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,494 | 18,461 | 22,580 | 19,137 | 23,350 |
| Receivables | 152,898 | 158,300 | 168,948 | 161,359 | 208,143 |
| Inventories | 40,906 | 44,462 | 47,585 | 49,169 | 43,371 |
| Other current assets | 10,196 | 9,987 | 12,872 | 12,774 | 12,710 |
| TOTAL | $238,547 | $242,223 | $266,648 | $256,728 | $301,820 |
| Non-Current Assets | |||||
| PPE Net | 143,211 | 146,965 | 148,452 | 147,961 | 149,014 |
| Intangibles | 188,200 | 191,682 | 191,385 | 175,071 | 175,106 |
| Other Non-Current Assets | 55,300 | 54,235 | 52,500 | 50,248 | 47,385 |
| TOTAL | $386,711 | $392,882 | $392,337 | $373,280 | $371,505 |
| Total Assets | $625,258 | $635,105 | $658,985 | $630,008 | $673,325 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 33,474 | 40,539 | 42,323 | 50,998 | 47,084 |
| Accrued Expenses | 36,475 | 33,016 | 38,412 | 38,128 | 34,617 |
| Other current liabilities | 25,480 | 20,148 | N/A | N/A | 19,624 |
| TOTAL | $120,758 | $124,063 | $136,880 | $131,526 | $131,866 |
| Non-Current Liabilities | |||||
| Long Term Debt | 430,987 | 428,000 | 421,508 | 373,000 | 353,672 |
| Deferred Revenues | 14,101 | 13,918 | 14,757 | 14,777 | 11,009 |
| Other Non-Current Liabilities | 92,155 | 86,262 | 87,193 | 86,786 | 86,047 |
| TOTAL | $528,199 | $516,957 | $514,845 | $465,937 | $447,466 |
| Total Liabilities | $648,957 | $641,020 | $651,725 | $597,463 | $579,332 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,376 | 42,366 | 42,570 | 42,810 | 43,322 |
| Common Shares | 1,142 | 1,142 | 1,174 | 1,174 | 1,174 |
| Retained earnings | 219,207 | 236,041 | 432,812 | 423,365 | 415,906 |
| Other shareholders' equity | -5,048 | -5,367 | -4,726 | -6,851 | -5,087 |
| TOTAL | $-23,699 | $-5,915 | $7,260 | $32,545 | $93,993 |
| Total Liabilities And Equity | $625,258 | $635,105 | $658,985 | $630,008 | $673,325 |